---
title: "ETC Complex III Fungicides Reduce Azole Antifungal Effectiveness"
id: "biorxiv-4-electron-transport-chain-inhibiting-fungicides-increase-resistance-to-widely"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-4-electron-transport-chain-inhibiting-fungicides-increase-resistance-to-widely"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ETC Complex III Fungicides Reduce Azole Antifungal Effectiveness
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-4-electron-transport-chain-inhibiting-fungicides-increase-resistance-to-widely
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators exposed the fission yeast **Schizosaccharomyces pombe** to electron transport chain (ETC) Complex III inhibitors and observed reduced sensitivity to **azole** antifungals. - The study team reported that ETC inhibition, whether applied prior to or simultaneously with azoles, impaired azole efficacy in their model organism. - Data indicated mitochondrial dysfunction followed ETC inhibition; this dysfunction correlated with decreased azole potency. - Authors noted that accumulation of reactive oxygen species (ROS) after ETC inhibition activated oxidative stress response pathways, and those responses contributed to lowered azole activity. - The cohort analysis extended these mechanistic observations to suggest similar responses in pathogenic fungi, although the preprint did not provide direct clinical or field trial data in human pathogens or crops. - The investigators concluded the common agricultural practice of pairing azole ergosterol inhibitors with ETC Complex III inhibitors may unintentionally promote **azole resistance** and therefore should be re-evaluated. - The article is a preprint and has not been peer reviewed; the authors declared no competing interests and listed funders supporting the work.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=eBTQWrNlzqh_RoByctJBvs..fXPCPkhlXsk7_Lzd3uQ-1795232201.63998-1.2.1.1-EyiBYypyAlS8dnwIh8wftLGzECp.Jda47bApyEU4N1GWb5mEs.JDKu9bQNqNF1SY) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Electron Transport Chain-inhibiting fungicides increase resistance to widely used azole antifungals Severina M Pociunaite, [ View ORCID Profile](http://orcid.org/0000-0002-2736-7414)Sharon Ann White, Pin Tong, Rebecca Yeboah, Alison L Pidoux, [ View ORCID Profile](http://orcid.org/0000-0002-8005-3625)Robin Allshire doi: https://doi.org/10.64898/2026.11.19.767815 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Severina M Pociunaite 1 University of Edinburgh; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Severina%2BM%2BPociunaite%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Pociunaite%20SM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASeverina%2BM%2BPociunaite%2B) Sharon Ann White 1 University of Edinburgh; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sharon%2BAnn%2BWhite%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=White%20SA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASharon%2BAnn%2BWhite%2B) * [ORCID record for Sharon Ann White](http://orcid.org/0000-0002-2736-7414 "Open in new tab") Pin Tong 1 University of Edinburgh; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pin%2BTong%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Tong%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APin%2BTong%2B) Rebecca Yeboah 2 National Institute of Environmental Health Sciences; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rebecca%2BYeboah%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Yeboah%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ARebecca%2BYeboah%2B) Alison L Pidoux 1 University of Edinburgh; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alison%2BL%2BPidoux%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Pidoux%20AL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAlison%2BL%2BPidoux%2B) Robin Allshire 3 - * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Robin%2BAllshire%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Allshire%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ARobin%2BAllshire%2B) * [ORCID record for Robin Allshire](http://orcid.org/0000-0002-8005-3625 "Open in new tab") * For correspondence: robin.allshire@ed.ac.uk * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5982245/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5982245/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5982245/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5982245/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Rising antifungal resistance in human and crop fungal pathogens poses significant challenges. Azole-based antifungals that inhibit ergosterol biosynthesis are a key first-line treatment for human fungal infections. Importantly, azole-based ergosterol-inhibiting fungicides are also widely used in agriculture alongside electron transport chain (ETC) Complex III inhibiting compounds. However, it is unknown whether the combined use of these distinct fungicides is entirely synergistic. We find that exposure of fission yeast, Schizosaccharomyces pombe to ETC-Complex III inhibitors, prior to or simultaneously with azoles, attenuates azole efficacy by inducing mitochondrial dysfunction. Our analyses show that reactive oxygen species (ROS) accumulation as a result of ETC inhibition activates oxidative stress response pathways thereby decreasing azole potency. Related responses in pathogenic fungi indicate that the use of ETC inhibiting fungicides in agriculture may inadvertently promote azole resistance. We conclude that the use of specific fungicide combinations should be re-evaluated in order to preserve both their clinical and agricultural effectiveness. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared Darwin Trust of Edinburgh PhD studentship Wellcome Principal Research Fellowship, 200885, 224358 Wellcome Centre for Cell Biology, 203149 Wellcome funded Discovery Research Platform for Hidden Cell Biology DRP-HCB, 226791 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.20.767314v1 "TrES-seq integrates single-cell RNA and nanobody-based histone mark profiles to decode epigenetic and transcriptional axes of cell identity")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.19.767834v1 "Multi-Cohort Blood Transcriptomic Meta-Analysis of Active Pulmonary Tuberculosis: Reproducibility of a 50-Gene Interferon Signature and Benchmarking of a 4-Gene Classifier") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767815v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.19.767815.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Electron Transport Chain-inhibiting fungicides increase resistance to widely used azole antifungals Severina M Pociunaite, Sharon Ann White, Pin Tong, Rebecca Yeboah, Alison L Pidoux, Robin Allshire bioRxiv 2026.11.19.767815; doi: https://doi.org/10.64898/2026.11.19.767815 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767815v1%26text%3DElectron%2520Transport%2520Chain-inhibiting%2520fungicides%2520increase%2520resistance%2520to%2520widely%2520used%2520azole%2520antifungals "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767815v1%26t%3DElectron%2520Transport%2520Chain-inhibiting%2520fungicides%2520increase%2520resistance%2520to%2520widely%2520used%2520azole%2520antifungals "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767815v1%26title%3DElectron%2520Transport%2520Chain-inhibiting%2520fungicides%2520increase%2520resistance%2520to%2520widely%2520used%2520azole%2520antifungals%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767815v1%26title%3DElectron%2520Transport%2520Chain-inhibiting%2520fungicides%2520increase%2520resistance%2520to%2520widely%2520used%2520azole%2520antifungals "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.19.767815) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.19.767815v1&count=horizontal&via=&text=Electron%20Transport%20Chain-inhibiting%20fungicides%20increase%20resistance%20to%20widely%20used%20azole%20antifungals&counturl=www.biorxiv.org/content/10.64898/2026.11.19.767815v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46179) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20386) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27666) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (
## Related Clinical Research

- [Macrophage Signaling History Shapes Later Cytokine-Induced Transcriptional Programs](https://medichelpline.com/clinical-feed/biorxiv-1-macrophage-signaling-history-constrains-subsequent-transcriptional-responses-to.md)
- [Distinct Maturation-Associated Neutrophil Transcriptional Programs in COVID-19 Versus Tuberculosis](https://medichelpline.com/clinical-feed/biorxiv-2-covid-19-and-active-tuberculosis-exhibit-distinct-maturation-associated.md)
- [Stakeholder preferences for long-acting injectables in tuberculosis treatment and prevention](https://medichelpline.com/clinical-feed/medrxiv-7-stakeholder-perspectives-and-preferences-for-long-acting-injectables-for.md)
- [Five-Year Trajectory of Autonomic Symptoms in Biologically Confirmed Parkinson's Disease](https://medichelpline.com/clinical-feed/medrxiv-23-longitudinal-investigation-of-autonomic-symptoms-in-biologically-confirmed-saa.md)
- [Extended Treatment Duration and Recurrence in Cavitary Drug-Susceptible Pulmonary Tuberculosis](https://medichelpline.com/clinical-feed/plos-one-11-extended-treatment-duration-and-recurrence-in-successfully-treated-drug.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.